Home > News > Industry > Pharma News > COVID: SII to give free...

COVID: SII to give free Covishield vials to pvt vaccination centres to compensate for price difference

"The difference between Rs 600 plus GST and our recent price of Rs 225 plus GST would be compensated in the form of free vials of the fresh stocks of Covishield," Singh is learnt to have conveyed in the communication.

By - Ruchika Sharma
Published On 2022-04-11 07:51 GMT   |   Update On 2024-02-16 10:16 GMT

New Delhi: A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India (SII) told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said.Vaccine majors SII and Bharat Biotech on...

Login or Register to read the full article
Register Now

New Delhi: A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India (SII) told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said.

Vaccine majors SII and Bharat Biotech on Saturday said they have decided to cut the prices of the precaution dose of their respective COVID-19 vaccines to Rs 225 per shot for private hospitals after discussions with the government.
Bharat Biotech had also announced that the price differential with any existing stocks of Covaxin in private hospitals shall be compensated in the form of additional doses.
In a communication to the Union health ministry, Prakash Kumar Singh, director, government and regulatory affairs at the SII, on Sunday said, "As per direction of Dr Adar C Poonawalla, we want to inform you that we will compensate the price difference for the current unexpired stocks lying with private Covid vaccination centres (CVCs)."
"The difference between Rs 600 plus GST and our recent price of Rs 225 plus GST would be compensated in the form of free vials of the fresh stocks of Covishield," Singh is learnt to have conveyed in the communication.
The inventories at the private CVCs would be verified by SII representatives and the claim would then be processed on the basis of their approval.
India began administering the precaution dose of COVID-19 vaccines to all beneficiaries aged above 18 years at private vaccination centres from Sunday.
Those above the age of 18 and who have completed nine months after the administration of the second dose of the vaccine will be eligible to receive the precaution dose.

Read also: Serum Institute Covishield Booster Shot to cost Rs 600 Per Shot

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease
Sentynl Therapeutics, a Zydus company acquires Zokinvy for Progeria from Eiger Biopharma
Walgreens, Boehringer Ingelheim partner to improve diversity in clinical trials
Lupin unveils Rymti biosimilar Etanercept in Canada
Aurobindo Pharma receives tax demand of over Rs 13 crore, including interest, penalty
Aurobindo Pharma arm gets 7 USFDA observations for Alwar facility
Delhi HC slaps Rs 3 lakh fine on drugmaker for violating Pfizer trademark of Viagra
Dr Reddy's Labs unveils Doxycycline Capsules, 40 mg in US to treat inflammatory lesions of rosacea